• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小 RNA 作为脂肪性肿瘤及其类似物鉴别诊断的潜在生物标志物。

MicroRNAs as Potential Biomarkers in the Differential Diagnosis of Lipomatous Tumors and Their Mimics.

机构信息

Department of Pathology, National University Hospital, National University Health System, Singapore 119074, Singapore.

MiRXES Lab, Singapore 138623, Singapore.

出版信息

Int J Mol Sci. 2022 Jul 15;23(14):7804. doi: 10.3390/ijms23147804.

DOI:10.3390/ijms23147804
PMID:35887151
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9322088/
Abstract

Adipocytic tumors are the most common subtype of soft tissue tumors. In current clinical practice, distinguishing benign lipomas from well-differentiated liposarcomas (WDLPS), as well as dedifferentiated liposarcomas (DDLPS) from their morphologic mimics, remains a significant diagnostic challenge. This is especially so when examining small biopsy samples and without the aid of additional ancillary tests. Recognizing the important role that microRNAs (miRNAs) play in tumorigenesis and their potential utility in tumor classification, we analyzed routine clinical tissue samples of benign and malignant lipomatous tumors, as well as other sarcoma mimics, to identify distinguishing miRNA-based signatures that can aid in the differential diagnosis of these entities. We discovered a 6-miRNA signature that separated lipomas from WDLPS with high confidence (AUC of 0.963), as well as a separate 6-miRNA signature that distinguished DDLPS from their more aggressive histologic mimics (AUC of 0.740). Functional enrichment analysis unveiled possible mechanistic involvement of these predictive miRNAs in adipocytic cancer-related biological processes and pathways such as PI3K/AKT/mTOR and MAPK signaling, further supporting the relevance of these miRNAs as biomarkers for adipocytic tumors. Our results demonstrate that miRNA expression profiling may potentially be used as an adjunctive tool for the diagnosis of benign and malignant adipocytic tumors. Further validation studies are warranted.

摘要

脂肪性肿瘤是软组织肿瘤中最常见的亚型。在当前的临床实践中,区分良性脂肪瘤与分化良好的脂肪肉瘤(WDLPS)以及去分化脂肪肉瘤(DDLPS)与其形态学模拟物仍然是一个重大的诊断挑战。在检查小的活检样本且没有辅助附加测试的情况下尤其如此。鉴于 microRNAs(miRNAs)在肿瘤发生中的重要作用及其在肿瘤分类中的潜在应用价值,我们分析了良性和恶性脂肪性肿瘤以及其他肉瘤模拟物的常规临床组织样本,以确定有助于这些实体的鉴别诊断的区分 miRNA 特征。我们发现了一个 6- miRNA 特征,可以高度置信地区分脂肪瘤与 WDLPS(AUC 为 0.963),以及另一个区分 DDLPS 与其更具侵袭性的组织学模拟物的 6- miRNA 特征(AUC 为 0.740)。功能富集分析揭示了这些预测性 miRNA 可能参与脂肪性癌症相关生物学过程和途径(如 PI3K/AKT/mTOR 和 MAPK 信号通路)的潜在机制,进一步支持这些 miRNA 作为脂肪性肿瘤生物标志物的相关性。我们的研究结果表明,miRNA 表达谱分析可能潜在地用作良性和恶性脂肪性肿瘤诊断的辅助工具。需要进一步的验证研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e57d/9322088/a26ddbb263fc/ijms-23-07804-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e57d/9322088/7694eaa45cad/ijms-23-07804-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e57d/9322088/e791a5dbf5dd/ijms-23-07804-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e57d/9322088/e651d288ebff/ijms-23-07804-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e57d/9322088/a26ddbb263fc/ijms-23-07804-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e57d/9322088/7694eaa45cad/ijms-23-07804-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e57d/9322088/e791a5dbf5dd/ijms-23-07804-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e57d/9322088/e651d288ebff/ijms-23-07804-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e57d/9322088/a26ddbb263fc/ijms-23-07804-g004.jpg

相似文献

1
MicroRNAs as Potential Biomarkers in the Differential Diagnosis of Lipomatous Tumors and Their Mimics.微小 RNA 作为脂肪性肿瘤及其类似物鉴别诊断的潜在生物标志物。
Int J Mol Sci. 2022 Jul 15;23(14):7804. doi: 10.3390/ijms23147804.
2
Atypical lipomatous tumor/well differentiated liposarcoma and related mimics with updates. When is molecular testing most cost-effective, necessary, and indicated?非典型性脂肪肿瘤/高分化脂肪肉瘤及相关模拟肿瘤的最新研究进展。何时进行分子检测最具成本效益、最必要和最有指示性?
Hum Pathol. 2024 May;147:82-91. doi: 10.1016/j.humpath.2023.12.005. Epub 2023 Dec 21.
3
Differential diagnosis of atypical lipomatous tumor/well-differentiated liposarcoma and dedifferentiated liposarcoma: utility of p16 in combination with MDM2 and CDK4 immunohistochemistry.非典型脂肪瘤样肿瘤/高分化脂肪肉瘤与去分化脂肪肉瘤的鉴别诊断:p16联合MDM2和CDK4免疫组化的应用价值
Hum Pathol. 2017 Jan;59:34-40. doi: 10.1016/j.humpath.2016.08.009. Epub 2016 Sep 3.
4
Characterization of the 12q amplicons in lipomatous soft tissue tumors by multiplex ligation-dependent probe amplification-based copy number analysis.通过基于多重连接依赖探针扩增的拷贝数分析对脂肪性软组织肿瘤中12q扩增子进行特征分析。
Anticancer Res. 2015 Apr;35(4):1835-42.
5
Lipomatous tumors.脂肪瘤性肿瘤
Monogr Pathol. 1996;38:207-39.
6
[Tumors with predominantly adipocytic morphology].[以脂肪细胞形态为主的肿瘤]
Pathologe. 2019 Jul;40(4):339-352. doi: 10.1007/s00292-019-0624-1.
7
Atypical Lipomatous Tumor/Well-Differentiated Liposarcoma With Features Mimicking Spindle Cell Lipoma.具有模仿梭形细胞脂肪瘤特征的非典型脂肪瘤性肿瘤/高分化脂肪肉瘤
Int J Surg Pathol. 2020 May;28(3):336-340. doi: 10.1177/1066896919884648. Epub 2019 Oct 31.
8
Update on Lipomatous Tumors with Emphasis on Emerging Entities, Unusual Anatomic Sites, and Variant Histologic Patterns.脂肪性肿瘤的最新进展,重点关注新出现的实体、不寻常的解剖部位和变异的组织学模式。
Surg Pathol Clin. 2019 Mar;12(1):21-33. doi: 10.1016/j.path.2018.11.001.
9
MDM4 amplification in atypical lipomatous tumors/well-differentiated liposarcoma: Private event or alternative oncogenic mechanism?非典型脂肪瘤性肿瘤/高分化脂肪肉瘤中的MDM4扩增:个别现象还是另一种致癌机制?
Genes Chromosomes Cancer. 2023 Jun;62(6):367-372. doi: 10.1002/gcc.23130. Epub 2023 Feb 21.
10
What's new in adipocytic neoplasia?脂肪细胞肿瘤有哪些新进展?
Virchows Arch. 2020 Jan;476(1):29-39. doi: 10.1007/s00428-019-02652-3. Epub 2019 Sep 9.

引用本文的文献

1
microRNAs in soft tissue sarcoma: State of the art and barriers to translation.软组织肉瘤中的微小RNA:现状与转化障碍
Oncotarget. 2025 Jul 16;16:560-561. doi: 10.18632/oncotarget.28754.
2
DEPDC1 facilitated malignant phenotypes and disease progression of liposarcoma by modulating KIF20A.DEPDC1通过调节KIF20A促进脂肪肉瘤的恶性表型和疾病进展。
Front Endocrinol (Lausanne). 2025 Jun 17;16:1591390. doi: 10.3389/fendo.2025.1591390. eCollection 2025.
3
miR-584-5p Regulates MSMO1 to Modulate the AKT/PI3K Pathway and Inhibit Breast Cancer Progression.

本文引用的文献

1
MDM2 Amplified Sarcomas: A Literature Review.MDM2基因扩增的肉瘤:文献综述
Diagnostics (Basel). 2021 Mar 11;11(3):496. doi: 10.3390/diagnostics11030496.
2
miR‑454‑3p inhibits non‑small cell lung cancer cell proliferation and metastasis by targeting TGFB2.miR-454-3p 通过靶向 TGFB2 抑制非小细胞肺癌细胞的增殖和转移。
Oncol Rep. 2021 May;45(5). doi: 10.3892/or.2021.8018. Epub 2021 Mar 24.
3
The diagnostic and prognostic values of microRNA-196a in cancer.miRNA-196a 在癌症中的诊断和预后价值。
miR-584-5p通过调控MSMO1调节AKT/PI3K信号通路并抑制乳腺癌进展。
Protein Pept Lett. 2025;32(3):171-182. doi: 10.2174/0109298665339026250114070523.
4
Deciphering the roles of non-coding RNAs in liposarcoma development: Challenges and opportunities for translational therapeutic advances.解读非编码RNA在脂肪肉瘤发生发展中的作用:转化治疗进展面临的挑战与机遇
Noncoding RNA Res. 2024 Nov 15;11:73-90. doi: 10.1016/j.ncrna.2024.11.005. eCollection 2025 Apr.
5
Genetic, Epigenetic and Transcriptome Alterations in Liposarcoma for Target Therapy Selection.用于靶向治疗选择的脂肪肉瘤中的遗传、表观遗传和转录组改变
Cancers (Basel). 2024 Jan 8;16(2):271. doi: 10.3390/cancers16020271.
6
The Predictive Role of the Histopathological Scoring System in Adipose Tumors-Lipoma, Atypical Lipomatous Tumor, and Liposarcoma.组织病理学评分系统在脂肪性肿瘤(脂肪瘤、非典型脂肪瘤性肿瘤和脂肪肉瘤)中的预测作用
Diagnostics (Basel). 2023 Dec 5;13(24):3606. doi: 10.3390/diagnostics13243606.
7
Small Non-Coding RNAs in Soft-Tissue Sarcomas: State of the Art and Future Directions.软组织肉瘤中的小型非编码 RNA:现状与未来方向。
Mol Cancer Res. 2023 Jun 1;21(6):511-524. doi: 10.1158/1541-7786.MCR-22-1008.
8
Tissue-Specific microRNA Expression Profiling to Derive Novel Biomarkers for the Diagnosis and Subtyping of Small B-Cell Lymphomas.组织特异性微小RNA表达谱分析以获取用于小B细胞淋巴瘤诊断和分型的新型生物标志物
Cancers (Basel). 2023 Jan 10;15(2):453. doi: 10.3390/cancers15020453.
Biosci Rep. 2021 Jan 29;41(1). doi: 10.1042/BSR20203559.
4
MicroRNA-454-3p inhibits cell proliferation and invasion in esophageal cancer by targeting insulin-like growth factor 2 mRNA-binding protein 1.微小RNA-454-3p通过靶向胰岛素样生长因子2信使核糖核酸结合蛋白1抑制食管癌细胞的增殖和侵袭。
Oncol Lett. 2020 Dec;20(6):359. doi: 10.3892/ol.2020.12223. Epub 2020 Oct 14.
5
MiR-196a promoted cell migration, invasion and the epithelial-mesenchymal transition by targeting HOXA5 in osteosarcoma.在骨肉瘤中,微小RNA-196a通过靶向HOXA5促进细胞迁移、侵袭及上皮-间质转化。
Cancer Biomark. 2020;29(2):291-298. doi: 10.3233/CBM-201674.
6
miR-221-3p and miR-15b-5p promote cell proliferation and invasion by targeting Axin2 in liver cancer.miR-221-3p和miR-15b-5p通过靶向肝癌中的Axin2促进细胞增殖和侵袭。
Oncol Lett. 2019 Dec;18(6):6491-6500. doi: 10.3892/ol.2019.11056. Epub 2019 Nov 5.
7
miR-374a-5p: A New Target for Diagnosis and Drug Resistance Therapy in Gastric Cancer.miR-374a-5p:胃癌诊断与耐药治疗的新靶点
Mol Ther Nucleic Acids. 2019 Dec 6;18:320-331. doi: 10.1016/j.omtn.2019.07.025. Epub 2019 Aug 27.
8
Animal models of well-differentiated/dedifferentiated liposarcoma: utility and limitations.高分化/去分化脂肪肉瘤的动物模型:效用与局限性
Onco Targets Ther. 2019 Jul 3;12:5257-5268. doi: 10.2147/OTT.S175710. eCollection 2019.
9
miR-454-3p promotes proliferation and induces apoptosis in human cervical cancer cells by targeting TRIM3.miR-454-3p 通过靶向 TRIM3 促进人宫颈癌细胞的增殖并诱导细胞凋亡。
Biochem Biophys Res Commun. 2019 Aug 27;516(3):872-879. doi: 10.1016/j.bbrc.2019.06.126. Epub 2019 Jun 30.
10
miR-454-3p exerts tumor-suppressive functions by down-regulation of NFATc2 in glioblastoma.miR-454-3p 通过下调 NFATc2 在胶质母细胞瘤中发挥肿瘤抑制功能。
Gene. 2019 Aug 20;710:233-239. doi: 10.1016/j.gene.2019.06.008. Epub 2019 Jun 7.